Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Comprehensive Income (Loss)

v3.22.4
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 25, 2021
Dec. 26, 2020
Income Statement [Abstract]      
Net sales $ 1,486,328 $ 1,425,967 $ 1,368,295
Cost of sales (exclusive of depreciation and amortization shown separately below) 846,551 859,557 781,815
Selling, General and Administrative Expense 480,993 437,875 398,472
Depreciation 57,815 59,400 67,423
Amortization 62,195 61,329 59,492
Management fees to related party 0 270 577
Other income, net (1,119) (2,778) (5,250)
Income from operations 39,893 10,314 65,766
Fair Value Adjustment of Warrants 0 (14,734) 0
Interest expense, net 54,560 61,237 86,774
Interest expense on junior subordinated debentures 0 7,775 12,707
Investment income on trust common securities 0 (233) (378)
Loss (income) on mark-to-market adjustment of interest rate swap 0 (1,685) 601
Refinancing costs 0 8,070 0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total (14,667) (50,116) (33,938)
Income tax expense (benefit) 1,769 (11,784) (9,439)
Net loss (16,436) (38,332) (24,499)
Net loss from above (16,436) (38,332) (24,499)
Other comprehensive income (loss):      
Foreign currency translation adjustments (7,615) (283) 2,652
Hedging activity 13,745 2,517 0
Total other comprehensive income 6,130 2,234 2,652
Comprehensive loss $ (10,306) $ (36,098) $ (21,847)
Basic and diluted loss per share $ (0.08) $ (0.28) $ (0.27)
Weighted average basic and diluted shares outstanding 194,249 134,699 89,891